ITCAN Launches Public Awareness Campaign for Zonnic Nicotine Pouches

Business by 2FIRSTS.ai
Apr.16.2024
ITCAN Launches Public Awareness Campaign for Zonnic Nicotine Pouches
ITCAN launches public campaign to educate about Zonnic nicotine pouches, aiming to dispel misunderstandings and promote smoking reduction in Canada.

According to a statement released by Imperial Tobacco Canada (ITCAN), the company has launched a public awareness campaign to broaden the public's knowledge of Zonnic nicotine pouches. The company stated that the goal of the campaign is to dispel misconceptions and provide accurate scientific information about nicotine replacement therapy (NRT) and how Zonnic can reduce tobacco use in Canada.

 

ITCAN President and CEO Frank Silva stated in a declaration, "Our new Zonnic advertising campaign affirms the statements about Zonnic nicotine pouches and reflects our dedication to reducing tobacco harm and commitment to helping Canada decrease smoking rates." The company pointed out that since Zonnic was launched in October last year, anti-tobacco lobbying groups and the federal health department have been making accusations and incorrect descriptions about it.

 

Silva stated: "Our goal is very clear; we want to help those who want to quit smoking, as long as they are willing to quit."

 

According to him, this initiative begins with the release of innovative and unique alternatives, ensuring that these products are readily available to adults while also preventing minors from accessing any form of nicotine products, including NRTs. Our stance includes the belief that any form of NRT should require age verification before purchase and be stored in a way that minors cannot access them in retail locations.

 

Silva said, "We have tried to meet with Minister Herland, our doors are always open to him, but he has not responded to our calls. We are very willing to have a fair, fact-based discussion to keep NRT available to adult smokers and prevent nicotine products from falling into the hands of teenagers. By working together, we can achieve the goals of your department, goals that we share."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
Rethink. Redefine. —— 2Firsts Global NGP Rethink Forum Held in Shenzhen
Rethink. Redefine. —— 2Firsts Global NGP Rethink Forum Held in Shenzhen
On July 25, 2Firsts successfully hosted the Global NGP Rethink Forum in Shenzhen. The event brought together leading experts from China and abroad in the novel tobacco industry for in-depth discussions on key topics including product design and trends, emerging market opportunities, and science-based harm reduction.
Jul.25 by 2FIRSTS.ai
U.S. Federal Court Rules FDA Tobacco Fines Unconstitutional, Case Could Undermine FDA's Regulatory Enforcement Tools
U.S. Federal Court Rules FDA Tobacco Fines Unconstitutional, Case Could Undermine FDA's Regulatory Enforcement Tools
On August 1, a Texas federal court ruled that the FDA's civil fines on tobacco products are unconstitutional, violating the Seventh Amendment right to a jury trial. The case, Vapor Lab, involved fines for selling unauthorized e-liquids. This ruling may weaken the FDA’s enforcement tools and lead to further legal challenges.
Aug.06 by 2FIRSTS.ai
ICA Seizes Over 18,400 E-Vaporisers at Tuas Checkpoint — Largest Land-Checkpoint Haul Since Tougher Penalties Took Effect
ICA Seizes Over 18,400 E-Vaporisers at Tuas Checkpoint — Largest Land-Checkpoint Haul Since Tougher Penalties Took Effect
Singapore’s Immigration & Checkpoints Authority (ICA) intercepted a Malaysian-registered lorry at Tuas Checkpoint and uncovered more than 18,400 e-vaporisers and about 1,400 related components misdeclared as “components for motorised external roll-up blinds.” ICA says this is the largest haul detected at land checkpoints since stiffer penalties for vape offences came into force on Sep 1, 2025. One Malaysian man was arrested and the case was referred to the Health Sciences Authority (HSA).
Sep.17 by 2FIRSTS.ai
Georgia Lawmakers Propose Tobacco Tax Hike and Flavored Vape Ban, Legislation May Reach Vote in 2026
Georgia Lawmakers Propose Tobacco Tax Hike and Flavored Vape Ban, Legislation May Reach Vote in 2026
A bipartisan panel in the Georgia House of Representatives is weighing new anti-tobacco measures, including a cigarette tax hike, flavored e-cigarette ban, and stricter licensing rules. Lawmakers say the bill could be introduced in 2026, though the plan faces resistance in an election year.
Sep.01 by 2FIRSTS.ai
Singapore Experts warn “vitamin diffusers” are not a healthy alternative to vapes; HSA steps up enforcement
Singapore Experts warn “vitamin diffusers” are not a healthy alternative to vapes; HSA steps up enforcement
Driven by social media promotion, “vitamin diffusers” are being marketed online as a healthier substitute for e-vaporisers. Singapore respiratory and pharmacy experts caution that ingredient lists are unclear, heating can generate unknown degradants, and there is no medical evidence of health benefits from inhaled vitamins. The Health Sciences Authority (HSA) recently fined a man found with a vitamin diffuser and reminded the public that imitation tobacco products are illegal. Authorities have a
Sep.04 by 2FIRSTS.ai